{"disease":{"id":"acute-spinal-cord-injury-sci","name":"acute spinal cord injury sci"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06000592","title":"Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Jill M. Wecht, Ed.D.","has_results":false},{"nct_id":"NCT07090473","title":"Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04278235","title":"Expanded Access to Elezanumab","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"AbbVie","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}